{"url_path":"/sec/eton/8-k/2026-04-27/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1710340/0001437749-26-013369-index.html","accession_number":"0001437749-26-013369","cik":"0001710340","ticker":"ETON","issuer_name":"Eton Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1710340/0001437749-26-013369-index.html","primary_entity_key":"0001710340","primary_entity_name":"Eton Pharmaceuticals, Inc."},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01: Financial Statements and Exhibits**\n\n \n\n**Exhibit No.**\n\n \n\n**Description**\n\n \n \n \n\n**Exhibit 99.1**\n \n[Press Release dated April 27, 2026](ex_940424.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n3\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: April 27, 2026\n\nBy:\n\n*/s/ James R. Gruber*\n\n \n \n\nJames R. Gruber\n\n \n \n\nChief Financial Officer and Secretary\n\n \n \n\n(Principal Financial Officer)\n\n \n\n4"}